Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
January 29, 2008 � A novel treatment for blood clots in the legs, in which injecting or �lacing� the clot with a ...
January 28, 2008 - MediGuide signed an agreement with Medtronic for co-development of medical positioning system-enabled products, providing Medtronic products with GPS-like navigation capabilities to enhance various procedures.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Terumo Interventional Systems offers the AZUR Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations and aneurysms, extending its interventional device portfolio.
January 28, 2008 - Terumo Interventional Systems launches the AZUR Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations and aneurysms, extending its interventional device portfolio.
Cheetah Medical Inc. said the FDA cleared for marketing the Reliant, a portable cardiac output monitor that provides a noninvasive window to cardiac and hemodynamic function.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
MEDecision Inc. introduced Alineo, a collaborative healthcare management platform for addressing case management, disease management and utilization management.
January 28, 2008 - Arbor Surgical Technologies Inc. closed a $20 million dollar Series C financing round led by ...
BD Diagnostics said it received clearance from the FDA for the BD GeneOhm StaphSR assay, which the company says is the first test to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) - Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) - from patients with positive blood cultures.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 28, 2008 - Inverness Medical Innovations will acquire Matria Healthcare, Inc. for approximately $1.18 billion, consisting of approximately $900 million to acquire the Matria shares of common stock and assumption of approximately $280 million of Matria's indebtedness outstanding, which will further Inverness' approach of bringing its proprietary diagnostic products into the home.
The FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.
January 28, 2008 - Toshiba America Medical Systems Inc. said today the FDA cleared the new open-bore 1.5T Vantage Titan ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Monitoring system maker Mennen Medical said an additional monitor, the VitaLogik 4000 Series, will soon be available for ...
January 28, 2008 – Medtronic Inc. has launched a clinical trial to confirm the safety and efficacy of the Medtronic ...
A new line of functional and comfortable tracheostomy tube holders that are offered with designs for babies, kids and ...
January 28, 2008
